By Professor Kate Dolan

Journal articles

Alam-Mehrjerdi Z; Daneshmand R; Samiei M; Samadi R; Abdollahi M; Dolan K, 2016, 'Women-only drug treatment services and needs in Iran: The first review of current literature', DARU, Journal of Pharmaceutical Sciences, 24, http://dx.doi.org/10.1186/s40199-016-0141-1

Noori R; Farhoudian A; Naranjiha H; Farhadi MH; Dolan K; Khoddami-Vishteh HR, 2016, 'Comparison of characteristics of methamphetamine versus opiate users in Tehran, Iran', International Journal of High Risk Behaviors and Addiction, 5, http://dx.doi.org/10.5812/ijhrba.28815

Edge CL; King EJ; Dolan K; McKee M, 2016, 'Prisoners co-infected with tuberculosis and HIV: A systematic review: A', Journal of the International AIDS Society, 19, pp. 20960, http://dx.doi.org/10.7448/IAS.19.1.20960

Alammehrjerdi Z; Ezard N; Clare P; Dolan K, 2016, 'Brief Cognitive-Behavioural Therapy for Methamphetamine Use among Methadone-Maintained Women: A Multicentre Randomised Controlled Trial', Journal of Addiction Research & Therapy, 7, pp. 1 - 8, http://dx.doi.org/10.4172/2155-6105.1000294

Alammehrjerdi Z; Moradi A; Fenglian X; Zarghami M; Salehi-Fadardi J; Dolan K, 2016, 'Willingness to receive treatment for hepatitis c among injecting drug users on methadone program: Implications for education and treatment', Addiction and Health, 8, pp. 1 - 8, http://ahj.kmu.ac.ir/index.php/ahj/article/view/384

Alam-Mehrjerdi Z; Moradi A; Xu F; Zarghami M; Salehi-Fadardi J; Dolan K, 2016, 'Willingness to Receive Treatment for Hepatitis C among Injecting Drug Users on Methadone Program: Implications for Education and Treatment.', Addict Health, 8, pp. 90 - 97, https://www.ncbi.nlm.nih.gov/pubmed/27882206

Dolan K; Worth H; Wilson D, 2015, 'Compulsory treatment of drug users in Asia: Designed to torture?', International Journal of Prisoner Health, 11, pp. 255 - 268, http://dx.doi.org/10.1108/IJPH-09-2014-0030

Larney S; Zador D; Sindicich N; Dolan K, 2015, 'PATIENT EXPERIENCES OF OPIOID SUBSTITUTION THERAPY IN PRISON: REASONS FOR SEEKING AND CEASING TREATMENT', DRUG AND ALCOHOL REVIEW, 34, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367694000106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J; Marks P; Amin J; Doab A; Carroll T; Teutsch S; Li H; Oon A; Cameron B; Lloyd A; White P; Rawlinson W; Jacqueline Flynn ; Goy K; Nguyen O; von Bibra S; Ffrench R; McCaughan G; Madden A; Farrell G; Crofts N; Sievert W; Baker D; Jacka B; Pan Y; Shaw D; Sasadeusz J; Crawford D; Phung N; George J; Bloch M; Hughes B; Mollison L; Roberts S; Desmond P; Acraman B, 2015, 'Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C', International Journal of Drug Policy, 26, pp. 976 - 983, http://dx.doi.org/10.1016/j.drugpo.2015.05.003

Ezard N; Hodge S; Dolan K, 2015, 'The development and evaluation of stimulant treatment programmes', Current Opinion in Psychiatry, 28, pp. 280 - 285, http://dx.doi.org/10.1097/YCO.0000000000000173

Alam-mehrjerdi Z; Abdollahi M; Higgs P; Dolan K, 2015, 'Drug use treatment and harm reduction programs in Iran: A unique model of health in the most populated Persian Gulf country', Asian Journal of Psychiatry, 16, pp. 78 - 83, http://dx.doi.org/10.1016/j.ajp.2015.06.002

Alam-mehrjerdi Z; Mokri A; Dolan K, 2015, 'Methamphetamine use and treatment in Iran: A systematic review from the most populated Persian Gulf country', Asian Journal of Psychiatry, 16, pp. 17 - 25, http://dx.doi.org/10.1016/j.ajp.2015.05.036

Iversen J; Dolan K; Ezard N; Maher L, 2015, 'HIV and hepatitis C virus infection and risk behaviors among heterosexual, bisexual, and lesbian women who inject drugs in Australia', LGBT Health, 2, pp. 127 - 134, http://dx.doi.org/10.1089/lgbt.2014.0116

Dolan K; Rodas A; Bode A, 2015, 'Drug and alcohol use and treatment for Australian Indigenous and non-Indigenous prisoners: Demand reduction strategies', International Journal of Prisoner Health, 11, pp. 30 - 38, http://dx.doi.org/10.1108/IJPH-02-2014-0005

Dolan K; Moazen B; Noori A; Rahimzadeh S; Farzadfar F; Hariga F, 2015, 'People who inject drugs in prison: HIV prevalence, transmission and prevention', International Journal of Drug Policy, 26, pp. S12 - S15, http://dx.doi.org/10.1016/j.drugpo.2014.10.012

Strathdee SA; West BS; Reed E; Moazan B; Azim T; Dolan K, 2015, 'Substance use and HIV among female sex workers and female prisoners: Risk environments and implications for prevention, treatment, and policies', Journal of Acquired Immune Deficiency Syndromes, 69, pp. S110 - S117, http://dx.doi.org/10.1097/QAI.0000000000000624

Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F; Dolan K; Haber P; Rawlinson W; Treloar C; Dore G; Maher L, 2015, 'Transmitted/founder viruses rapidly escape from CD8⁺ T cell responses in acute hepatitis C virus infection', Journal of Virology, 89, pp. 5478 - 5490, http://dx.doi.org/10.1128/JVI.03717-14

Treloar C; McCredie L; Lloyd AR; Dolan K, 2015, 'Acquiring hepatitis C in prison: the social organisation of injecting risk', Harm Reduction Journal, 12, pp. 10, http://dx.doi.org/10.1186/s12954-015-0045-2

Bretaña N; Boelen L; Bull R; Teutsch S; White P; Lloyd A; Luciani F; Bretana N; Dolan K; Rawlinson W; Dore G; Maher L, 2015, 'Transmission of Hepatitis C Virus among Prisoners, Australia, 2005–2012.', Emerging Infectious Diseases, 21, pp. 765 - 774, http://dx.doi.org/10.3201/eid2105.141832

Alam-mehrjerdi Z; Noori R; Dolan K, 2014, 'Opioid use, treatment and harm reduction services: the first report from the Persian Gulf region', Journal of Substance Use, http://dx.doi.org/10.3109/14659891.2014.966344

Luciani F; Bretaña NAR; Teutsch S; Amin J; Topp L; Dore GJ; Maher L; Dolan K; Lloyd AR; Bretana N, 2014, 'A prospective study of hepatitis C incidence in Australian prisoners', Addiction (Abingdon, England), 109, pp. 1695 - 1706, http://dx.doi.org/10.1111/add.12643

Luciani F; Bretaña NAR; Teutsch S; Amin J; Topp L; Dore GJ; Maher L; Dolan K; Lloyd AR; Bretana N, 2014, 'A prospective study of hepatitis C incidence in Australian prisoners', Addiction (Abingdon, England), 109, pp. 1695 - 1706, http://dx.doi.org/10.1111/add.12643

Hajarizadeh B; Grebely J; Applegate T; Matthews GV; Amin J; Petoumenos K; Hellard M; Rawlinson W; Lloyd A; Kaldor J; Dore GJ; Dolan K, 2014, 'Dynamics of HCV RNA Levels During Acute Hepatitis C Virus Infection', Journal of Medical Virology, 86, pp. 1722 - 1729, http://dx.doi.org/10.1002/jmv.24010

Boelen L; Teutsch S; Wilson DP; Dolan K; Dore GJ; Lloyd AR; Luciani F; Maher L, 2014, 'Per-event probability of hepatitis C infection during sharing of injecting equipment', PLoS ONE, 9, pp. e100749, http://dx.doi.org/10.1371/journal.pone.0100749

Dolan K; Rodas A, 2014, 'Detection of drugs in Australian prisons: Supply reduction strategies', International Journal of Prisoner Health, 10, pp. 111 - 117, http://dx.doi.org/10.1108/IJPH-06-2013-0025

Sugden PB; Cameron B; Mina M; Lloyd AR; Luciani F; Maher L; Dolan K, 2014, 'Protection against hepatitis C infection via NK cells in highly-exposed uninfected injecting drug users', Journal of Hepatology, 61, pp. 738 - 745, http://dx.doi.org/10.1016/j.jhep.2014.05.013

Flynn JK; Dore GJ; Hellard M; Yeung B; Rawlinson WD; White PA; Kaldor JM; Lloyd AR; Ffrench RA; Dolan K, 2013, 'Maintenance of Th1 hepatitis C virus (HCV)-specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment', Journal of Gastroenterology and Hepatology (Australia), 28, pp. 1770 - 1781, http://dx.doi.org/10.1111/jgh.12265

Cameron B; Galbraith S; Li H; Lloyd A; HITS investigators , 2013, 'Correlates and characteristics of hepatitis C virus-specific T-cell immunity in exposed uninfected high-risk prison inmates', Journal of Viral Hepatitis, 20, pp. e96 - e106, http://dx.doi.org/10.1111/jvh.12016

Mccredie L; Luciani F; Teutsch S; Amin J; Topp L; Dolan K; Lloyd A, 2012, 'BLOODY PRISONS: INCIDENCE OF RISK BEHAVIOURS AND HEPATITIS C VIRUS TRANSMISSION IN AN AUSTRALIAN PRISONER COHORT', DRUG AND ALCOHOL REVIEW, 31, pp. 57 - 57, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311236700175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Grebely J; Alavi M; Spelman T; Haber P; Day C; Matthews G; Van Beek I; Walsh N; Yeung B; Petoumenos K; Dolan K; Kaldor J; Dore G; Hellard M, 2012, 'IMPACT OF TREATMENT OF RECENTLY-ACQUIRED HEPATITIS C INFECTION ON INJECTING DRUG USE BEHAVIOURS', DRUG AND ALCOHOL REVIEW, 31, pp. 34 - 34

Larney S; Toson B; Burns L; Dolan K, 2012, 'Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration', Addiction, 107, pp. 372 - 380, http://dx.doi.org/10.1111/j.1360-0443.2011.03618.x

Grebely J; Matthews GV; Petoumenos K; Yeung B; Day C; Lloyd AR; Beek IV; Kaldor JM; Hellard M; Dore GJ; Haber PS; Alavi M; Van Beek I; Amin J; Dolan K; Rawlinson W; Flynn J; Marks P; Acraman B; Bloch M; Li H; Madden A; George J, 2012, 'Effect of pegylated interferon-a-2a treatment on mental health during recent hepatitis C virus infection', Journal of Gastroenterology and Hepatology, 27, pp. 957 - 965, http://dx.doi.org/10.1111/j.1440-1746.2011.07035.x

Larney S; Toson B; Burns LA; Dolan K, 2012, 'Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration', Addiction, 107, pp. 372 - 380, http://dx.doi.org/10.1111/j.1360-0443.2011.03618.x/pdf

Grebely J; Pham ST; Matthews G; Petoumenos K; Bull RA; Yeung B; Rawlinson WD; Kaldor JM; Lloyd AR; Hellard M; Dore GJ; White PA; Bull ; Dolan K, 2012, 'Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection', Hepatology, 55, pp. 1058 - 1069, http://dx.doi.org/10.1002/hep.24754

Flynn J; Dore GJ; Matthews G; Hellard M; Yeung B; Rawlinson W; White PA; Kaldor JM; Lloyd AR; Ffrench RA; Dolan K, 2012, 'Impaired hepatitis C virus (HCV)-specific interferon-responses in individuals with HIV who acquire HCV infection: Correlation with CD4 + T-cell counts', Journal of Infectious Diseases, 206, pp. 1568 - 1576, http://dx.doi.org/10.1093/infdis/jis544

Gargari SS; Fallahian M; Haghighi L; Hosseinnezhad-Yazdi M; Dashti E; Dolan K, 2012, 'Maternal and neonatal complications of substance abuse in Iranian pregnant women', Acta Medica Iranica, 50, pp. 411 - 416, http://journals.tums.ac.ir/upload_files/pdf/_/21203.pdf

Dolan K; Salimi S; Nassirimanesh B; Mohsenifar S; Allsop D; Mokri A, 2012, 'Six-month follow-up of Iranian women in methadone treatment: Drug use, social functioning, crime, and HIV and HCV seroincidence', Susbtance Abuse and Rehabilitation, 3, pp. 37 - 43, http://www.dovepress.com/six-month-follow-up-of-iranian-women-in-methadone-treatment-drug-use-s-peer-reviewed-article-SAR

Grebely J; Hellard M; Applegate TL; Petoumenos K; Yeung B; Feld J; Rawlinson WD; Lloyd AR; George J; Kaldor JM; Dore GJ; Matthews G; Dolan K, 2012, 'Virological responses during treatment for recent hepatitis C virus: Potential benefit for ribavirin use in HCV/HIV co-infection', AIDS, 26, pp. 1653 - 1661, http://dx.doi.org/10.1097/QAD.0b013e3283553719

Larney S; Toson B; Burns L; Dolan K, 2011, 'RE-INCARCERATION FOLLOWING PRISON-BASED OPIOID SUBSTITUTION TREATMENT', DRUG AND ALCOHOL REVIEW, 30, pp. 52 - 52, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297019700159&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dolan K, 2011, 'Do women and men know different things? Measuring gender differences in political knowledge', Journal of Politics, 73, pp. 97 - 107, http://dx.doi.org/10.1017/S0022381610000897

Grebely J; Matthews G; Hellard M; Shaw D; van Beek I; Petoumenos K; Alavi M; Yeung B; Haber P; Lloyd AR; Kaldor JM; Dore GJ; Dolan K, 2011, 'Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users', Journal of Hepatology, 55, pp. 76 - 85, http://dx.doi.org/10.1016/j.jhep.2010.10.033

Dolan K; Salimi S; Nassirimanesh B; Mohsenifar S; Allsop D; Mokri A, 2011, 'Characteristics of Iranian women seeking drug treatment', Journal of Women's Health, 20, pp. 1687 - 1691, http://dx.doi.org/10.1089/jwh.2010.2694

Flynn JK; Dore GJ; Hellard M; Yeung B; Rawlinson WD; White PA; Kaldor JM; Lloyd AR; Ffrench RA; Dolan K, 2011, 'Early IL-10 predominant responses are associated with progression from acute to chronic hepatitis C virus infection in injecting drug users', Journal of Viral Hepatitis, 18, pp. 549 - 561, http://dx.doi.org/10.1111/j.1365-2893.2010.01335.x

Dolan K; Salimi S; Nassirimanesh B; Mohsenifar S; Mokri A, 2011, 'The establishment of a methadone treatment clinic for women in Tehran, Iran', Journal of Public Health Policy, 32, pp. 219 - 230, http://www.palgrave-journals.com/jphp/journal/v32/n2/full/jphp201110a.html

Grebely J; Petoumenos K; Matthews G; Haber PS; Marks P; Lloyd AROLA; Kaldor JM; Dore GJ; Hellard M; Dolan K, 2010, 'Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study', Drug and Alcohol Dependence, 107, pp. 244 - 249, http://dx.doi.org/10.1016/j.drugalcdep.2009.09.015

Larney S; Dolan K, 2010, 'Compulsory detoxification is a major challenge to harm reduction in China', International Journal of Drug Policy, 21, pp. 165 - 166, http://dx.doi.org/10.1016/j.drugpo.2009.05.001

Dore GJ; Hellard M; Matthews G; Grebely J; Haber PS; Petoumenos K; Yeung B; Marks P; Van Beek IA; McCaughan G; White PA; French R; Rawlinson WD; Lloyd AROLA; Kaldor JM; Dolan K, 2010, 'Effective treatment of injecting drug users with recently acquired hepatitis C virus infection', Gastroenterology, 138, pp. 123 - 135, http://dx.doi.org/10.1053/j.gastro.2009.09.019

Dolan K; Larney S, 2010, 'HIV in Indian prisons: Risk behaviour, prevalence, prevention and treatment', Indian Journal of Medical Research, 132, pp. 696 - 700

Dolan K; Teutsch S; Scheuer N; Levy M; Rawlinson WD; Kaldor JM; Lloyd AROLA; Haber P, 2010, 'Incidence and risk for acute hepatitis C infection during imprisonment in Australia', European Journal of Epidemiology, 25, pp. 143 - 148, http://dx.doi.org/10.1007/s10654-009-9421-0

Teutsch S; Luciani F; Scheuer N; McCredie L; Hosseiny P; Rawlinson WD; Kaldor JM; Dore GJ; Dolan K; Ffrench R; Lloyd AROLA; Haber P; Levy MH, 2010, 'Incidence of primary Hepatitis C infection and risk factors for transmission in an Australian prisoner cohort', BMC Public Health, 10, pp. 1 - 9, http://dx.doi.org/10.1186/1471-2458-10-633

Back to profile page